This could potentially result in further abnormalities of conduction or provide a re-entrant circuit for excitation waves around the partially inexcitable pulmonary veins, suggesting IK1 blockers may be unsuitable for management of AF mediated by the E299V-Kir2.1 mutation. Here, KCNJ2 is linked to atrial fibrillation.